Cargando…

AKAP4, SPAG9 and NY-ESO-1 in Iranian Colorectal Cancer Patients as Probable Diagnostic and Prognostic Biomarkers

BACKGROUND AND OBJECTIVES: Colorectal cancer (CRC) is the most common gastrointestinal cancer and the second leading cause of cancer death in women in the world. Cancer-Testis Antigens (CTAs) are a group of tumor-associated proteins which typically are expressed in normal reproductive cells of men,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koudehi, Ameneh Tavakoli, Mahjoubi, Bahar, Mirzaei, Rezvan, Shabani, Samira, Mahjoubi, Frouzandeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980935/ https://www.ncbi.nlm.nih.gov/pubmed/29480665 http://dx.doi.org/10.22034/APJCP.2018.19.2.463

Ejemplares similares

Prognostic Value of FBXO39 and ETS-1 but not BMI-1 in Iranian Colorectal Cancer Patients
por: Motalebzadeh, Jamshid, et al.
Publicado: (2018)

A Panel of Cancer Testis Antigens and Clinical Risk Factors to Predict Metastasis in Colorectal Cancer
por: Molania, Ramyar, et al.
Publicado: (2014)

Extracellular matrix protein 1 gene (ECM1) mutations in nine Iranian families with lipoid proteinosis
por: Izadi, Farzad, et al.
Publicado: (2016)

Novel EPG5 Mutation Associated with Vici Syndrome Gene
por: Mahjoubi, Frouzandeh, et al.
Publicado: (2022)

Characterization of pathways involved in colorectal cancer using real-time RT-PCR gene expression data
por: Shabani, Samira, et al.
Publicado: (2021)

Identification of two novel homozygous nonsense mutations in TRAPPC9 in two unrelated consanguineous families with intellectual Disability from Iran
por: Yousefipour, Farideh, et al.
Publicado: (2021)

Successful management of multiple small bowel perforations due to polyarteritis nodosa
por: Mousavie, Seyed Hamzeh, et al.
Publicado: (2014)

MRP1 but Not MDR1 Is Associated with Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Taheri, Mohsen, et al.
Publicado: (2013)

Multi-stage analysis of FOXM1, PYROXD1, hTERT, PPARA, PIM3, BMI1 and MCTP1 expression patterns in colorectal cancer
por: Shabani, Samira, et al.
Publicado: (2022)

A cross-sectional survey of quality of life in colostomates: a report from Iran
por: Mahjoubi, Bahar, et al.
Publicado: (2012)

Chromosomal Abnormalities in Infertile Men Referred to Iran Blood Transfusion Organization Research Center
por: Mahjoubi, Frouzandeh, et al.
Publicado: (2010)

Expression of LRP Gene in Breast Cancer Patients Correlated with MRP1 as Two Independent Predictive Biomarkers in Breast Cancer
por: Taheri, Mohsen, et al.
Publicado: (2018)

The Effects of Cognitive Behavioral Therapy with Biofeedback Therapy on the Quality of Life, Anxiety, Depression and Somatic Symptoms in Patients with Dyssynergic Defecation: A Randomized Controlled Trial
por: Nikjooy, Afsaneh, et al.
Publicado: (2022)

Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141(+) dendritic cells to activate naïve and memory NY-ESO-1-specific CD8(+) T cells
por: Masterman, Kelly-Anne, et al.
Publicado: (2020)

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
por: Thomas, Remy, et al.
Publicado: (2018)

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors
por: Ishihara, Mikiya, et al.
Publicado: (2020)

Aberrant DNA Methylation of Two Tumor Suppressor Genes, p14(ARF) and p15(INK4b), after Chronic Occupational Exposure to Low Level of Benzene
por: Jamebozorgi, Iraj, et al.
Publicado: (2018)

LRIG1 expression and colorectal cancer prognosis
por: Bakherad, Maryam, et al.
Publicado: (2021)

Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells
por: Gong, Wenjie, et al.
Publicado: (2021)

Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients
por: Kageyama, Shinichi, et al.
Publicado: (2013)

A new method for treating fecal incontinence by implanting stem cells derived from human adipose tissue: preliminary findings of a randomized double-blind clinical trial
por: Sarveazad, Arash, et al.
Publicado: (2017)

Nebulette Expression Is Associated with Lymph Node Metastasis in Patients with Colorectal Cancer
por: Hosseini, Sayed Mostafa, et al.
Publicado: (2018)

Investigation of FANCA gene in Fanconi anaemia patients in Iran
por: Saffar Moghadam, Ali Akbar, et al.
Publicado: (2016)

NY-ESO-1 antibody as a novel tumour marker of gastric cancer
por: Fujiwara, S, et al.
Publicado: (2013)

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma
por: Giesen, Eva, et al.
Publicado: (2014)

NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target
por: Lai, Jin-Ping, et al.
Publicado: (2012)

NY-ESO-1 expression in DCIS: A new predictor of good prognosis
por: Coombes, R. Charles, et al.
Publicado: (2017)

Involvement of NY-ESO-1 and MAGE-A4 in the pathogenesis of desmoid tumors
por: Hashimoto, Kazuhiko, et al.
Publicado: (2023)

Pushing forward in sarcoma with a new TCR targeting NY-ESO-1
por: Al-Marayaty, Rusul, et al.
Publicado: (2023)

Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4(+)T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma
por: Jäger, Elke, et al.
Publicado: (2000)

Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
por: Sarvari, Pourya, et al.
Publicado: (2022)

Tumor-Infiltrating T Cells Correlate with NY-ESO-1-Specific Autoantibodies in Ovarian Cancer
por: Milne, Katy, et al.
Publicado: (2008)

NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability
por: Sommermeyer, Daniel, et al.
Publicado: (2013)

Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma
por: Zhang, Zhen, et al.
Publicado: (2017)

Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma
por: Gyurdieva, Alexandra, et al.
Publicado: (2022)

Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment
por: Zhou, Hong, et al.
Publicado: (2023)

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
por: Dyrskjøt, L, et al.
Publicado: (2012)

Deep phenotypic characterization of NY-ESO TCR engineered T cells and tumor in patients with advanced myeloma
por: Davila, Eduardo, et al.
Publicado: (2015)

Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma
por: Giavina-Bianchi, Mara, et al.
Publicado: (2015)

NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma
por: Liu, Zhenjiang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_un61u5lcu7tq8lkbi1lekp125j